David McEneaney

Papers

Total Citations

H-Index

About

David McEneaney is a leading figure in cardiovascular diagnostics, with a primary focus on the early detection of acute myocardial infarction and the development of novel biosensing technologies. His most influential work includes a seminal systematic review and meta-analysis on heart-type fatty acid-binding protein (H-FABP) for the early diagnosis of heart attacks, a study that has garnered significant attention and shaped clinical practice. Beyond traditional biomarkers, McEneaney has pioneered innovative approaches in synthetic biology, proposing a direct protein (DiPro) biosensor mechanism that bypasses conventional gene expression cascades for rapid, specific chemical detection. This forward-looking research bridges the gap between molecular diagnostics and synthetic biology, offering new pathways for point-of-care testing. With over 8 citations on his landmark meta-analysis alone, his contributions have had a measurable impact on both clinical cardiology and bioengineering. McEneaney’s work exemplifies a commitment to translating fundamental biological insights into practical, life-saving diagnostic tools, making him a key voice in the evolution of cardiovascular medicine and biosensor design.